Drug Database
CE

cefazolin dibenzylamine (Daren)

✓ Approved

Pfizer, Inc. · 小分子 · 小分子

什么是 cefazolin dibenzylamine?

cefazolin dibenzylamine 是一种小分子,由Pfizer, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Daren
公司Pfizer, Inc.
药物类别小分子
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

cefazolin dibenzylamine 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsUrinary tract infection✓ Approved
Infections and infestationsRespiratory tract infection✓ Approved

相关研究文献

PubMedAnaesthesia, critical care & pain medicine2026-11-18

Scoping review on dosing of anaesthetic and perioperative drugs in patients with obesity: which body weight for which molecule.

Gouel-Chéron Aurélie A, Aubrun Frédéric F, Aubrun Frédéric F, Garnier Marc M et al.

The prevalence of obesity is rising. Patients with obesity are increasingly exposed to anaesthesia, critical care, and perioperative pharmacotherapy. Obesity alters drug pharmacokinetics in a non-linear, drug-specific manner, so that simply scaling doses to total body weight (TBW) exposes patients to overdose or underdose. A recurring clinical question is therefore: which body weight descriptor should be used for which molecule? This review was conducted in accordance with the PRISMA extension for Scoping Reviews. We synthesized pharmacokinetic evidence, recent meta-analyses, and French and European guidelines on dose adjustment in adults with obesity for five drug classes of anaesthesia and critical care: hypnotics, opioids, neuromuscular blocking agents (NMBA), perioperative antibiotics, and non-opioid analgesics. We summarised the recommended dosing weight for each molecule in a table and a figure. No single weight descriptor applies. Lipophilic induction agents (propofol), most opioids (alfentanil, fentanyl, sufentanil), and non-depolarising NMBA are best dosed on lean or ideal body weight, whereas succinylcholine, neuromuscular reversal, and aminoglycosides use total or adjusted body weight. Maintenance of hypnosis and pain management in the post-anaesthesia care unit are titrated to monitored effect. Cephalosporin-based antibiotic prophylaxis relies on fixed doses (e.g., cefazolin 2 g) up to high body mass index values due to their hydrophilic properties. Paracetamol and non-steroidal anti-inflammatory drugs are given at standard doses and never scaled to TBW. Findings are consolidated in a single bedside reference table. Dosing in obesity must be molecule-specific, guided by the relevant weight descriptor and by intraoperative monitoring rather than by TBW alone.

PMID 43051533
阅读全文 →
PubMedBMC complementary medicine and therapies2026-11-18

Salvia willeana (Holmboe) Hedge extract as a natural dual-action agent: anti-inflammatory and antimicrobial synergy.

Oduncuoglu Goksu G, Şanlıtürk Gizem G

Salvia comprises valuable species are rich in phenolic compounds and possess medicinal activities. Salvia willeana (Holmboe) Hedge is known as Troodos sage, endemic to Cyprus and has strong antiseptic activity. This study investigates the potential synergistic anti-inflammatory effects of S. willeana extract combined with non-steroidal anti-inflammatory agents and evaluates the extract's enhancement of antimicrobial activity of selected antibiotics against Methicillin-resistant Staphylococcus aureus (MRSA). The phenolic compounds of methanol extract from S. willeana were investigated by means of LC-MS/MS. Anti-inflammatory activity of the extract (30-300 µg/mL) was evaluated alone and in combination with diclofenac sodium through the protein denaturation inhibition assay. The antimicrobial activity of S. willeana extract against MRSA (ATCC 33591) was investigated using microdilution assay. A checkerboard assay was performed to evaluate the combinatory effect of the extract in combination with different antibiotics against MRSA. For statistical analysis, one-way ANOVA, post hoc Tukey's multiple comparisons test and chi-square test were used. Twenty-two phenolic compounds in S. willeana methanol extract were detected and rosmarinic acid and jaceosidin were found as the major compounds. The total phenolic and flavonoid contents were calculated as 314.98 ± 11.67 mg GAE/g and 156.30 ± 7.39 mg QE/g dry extract, respectively. S. willeana methanol extract showed concentration-dependent anti-inflammatory activity. Furthermore, the extract has a lower IC50 (109.4 µg/mL) relative to standard diclofenac sodium (434.0 µg/mL). The combination of S. willeana extract and diclofenac sodium showed a synergistic interaction since the experimental IC50 (Zexp = 14.90 µg/mL) was lower than the theoretical (Zadd = 271.7 µg/mL). MIC and MBC of S. willeana extract against MRSA were determined as 125 µg/mL. The combination of β-lactam (ampicillin, cefazolin) and aminoglycoside (kanamycin, streptomycin) antibiotics with the extract resulted in synergistic interactions (FICI < 0.5) whereas, the combination of chloramphenicol with the extract showed an indifferent effect (FICI = 2.0). The dual anti-inflammatory and antimicrobial activity of S. willeana extract highlight its potential for the treatment of inflammatory bacterial infections.

PMID 43046015
阅读全文 →
PubMedCureus2026-11-16

A Case Report of Intraoperative Shock Following Spinal Anesthesia: Could It Be All of the Above?

Sousa Ana A, Saraiva Rita R, Camões Pedro P, Borges Rita R

Perioperative cardiovascular collapse may result from several life-threatening conditions with overlapping clinical manifestations, making the diagnosis challenging. We present a case of a 37-year-old man with morbid obesity who underwent fixation of a tibial plateau fracture. Following an uneventful ultrasound-guided femoral nerve block and spinal anesthesia, intravenous cefazolin was administered. Within minutes, the patient developed lightheadedness, nausea, loss of consciousness, jaw rigidity, and severe hypotension, refractory to fluid administration and vasopressor boluses, followed by bradycardia and respiratory distress. Point-of-care echocardiography showed preserved biventricular function and findings suggestive of marked hypovolemia, without right ventricular dysfunction. One hour after hemodynamic stabilization, the patient developed a maculopapular rash. Serial serum tryptase concentrations were markedly elevated, supporting the diagnosis of perioperative anaphylaxis. The patient recovered uneventfully and was referred to an allergy and immunology specialist. This case highlights the complexity of diagnosing sudden cardiovascular collapse during neuraxial anesthesia when several potentially life-threatening conditions are considered. Perioperative anaphylaxis should always be considered in cases of unexplained severe hypotension, even in the absence of bronchospasm or cutaneous manifestations.

PMID 43036755
阅读全文 →
PubMedBJU international2026-11-16

Continuous vs stent-removal antibiotic prophylaxis after cystectomy: a retrospective analysis.

McDonald Sam S, Keane Kevin G KG, Votrubec Alexandra A, Tiong Ruth R et al.

To compare the efficacy and microbiological consequences of continuous prophylaxis (CP) vs stent-removal prophylaxis (SRP) in patients undergoing cystectomy with urinary diversion. This single-centre retrospective cohort study included 223 patients undergoing cystectomy with urinary diversion from 2015 to 2024. All patients received identical perioperative intravenous prophylaxis (cefazolin and metronidazole for up to 48 h). Groups were defined by the subsequent oral strategy: SRP (n = 119), a 3-day course of amoxicillin-clavulanate around stent removal, vs CP (n = 104), amoxicillin-clavulanate given continuously from completion of intravenous prophylaxis until the day after stent removal. Primary endpoints included surgical site infection (SSI), urinary tract infection (UTI), readmission rates, and new isolation of organisms not covered by the prophylactic regimen. Multivariable logistic and negative binomial regression models adjusted for pre-specified confounders. The CP group had a higher median Charlson Comorbidity Index (4 vs 3, P = 0.023). Despite a median antibiotic duration of 16.0 (CP) vs 7.0 days (SRP) (P < 0.001), no significant differences were observed in UTI (27.9% vs 31.9%, P = 0.6), SSI (28.8% vs 28.6%, P > 0.9), or 30-day readmission (26.0% vs 29.4%, P = 0.7). CP was associated with significantly higher isolation of new organisms not covered by the prophylactic regimen (32.7% vs 19.3%, P = 0.031) and new Pseudomonas aeruginosa isolation (15.4% vs 2.5%, P < 0.001). CP was associated with postoperative Pseudomonas isolation after adjustment using Firth's penalised logistic regression (odds ratio 5.50, 95% confidence interval 1.77-22.36, P = 0.002). Continuous prophylaxis was not associated with fewer infectious complications or readmissions but was associated with increased isolation of organisms not covered by prophylaxis, particularly P. aeruginosa. Given the non-randomised historical before-after design, non-overlapping study periods, and baseline differences, these findings remain hypothesis-generating.

PMID 43039439
阅读全文 →
PubMedAntimicrobial stewardship & healthcare epidemiology : ASHE2026-11-15

Cefazolin-associated coagulopathy in a critically Ill patient with MSSA bacteremia: a case report.

Sicignano Dakota D, Gray Julie J

We report a case of cefazolin-induced coagulopathy in a patient with a methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia. Medical intensive care unit at a 1,500-bed, tertiary medical center. A 74-year-old male presented to the medical intensive care unit with septic shock secondary to a left skin and soft tissue infection. Blood cultures resulted positive for and the patient was initiated on cefazolin therapy. Shortly after initiation of therapy, patient lab work showed an increased INR to a max of >9.67. Hematology was consulted, and further work-up revealed a clotting deficiency consistent with a vitamin K-mediated coagulopathy. Intravenous vitamin K was administered, and the patient had rapid correction of their INR. Therapy was switched to oxacillin for the completion of treatment with no further cases of coagulopathy. Cefazolin-associated coagulopathy, though rare, should be considered in patients with unexplained INR elevation during therapy. Early recognition is critical, as discontinuation of the offending agent and administration of vitamin K can rapidly reverse coagulopathy. Clinicians should maintain heightened awareness in critically ill patients, particularly when additional risk factors for coagulopathy are present.

PMID 43032291
阅读全文 →
PubMedThe Journal of allergy and clinical immunology2026-11-13

A novel mast cell-dependent mouse model of cefazolin-induced anaphylaxis using a cefazolin-self-protein conjugate.

Gonzalez-Estrada Alexei A, Iijima Koji K, Richards Amanda M AM, Estrada-Mendizabal Ricardo J RJ et al.

PMID 43023965
阅读全文 →

注册免费账户还可查看另外 6339 篇文献

免费注册查看全部文献 →

了解更多cefazolin dibenzylamine